Effects of CS-1 on A431 cell proliferation, cell cycle, and epidermal growth factor receptor signal transduction
CS-1, a new alkaloid with a molecular formula of C21H2oOsN2S, is extracted from traditional Chinese medi- cine. Previous studies have shown that CS-1 can inhibit the proliferation of several human carcinoma cells in vivo and in vitro. The aims of this study are to investigate the anti-tumor effect a...
Saved in:
Published in | Acta biochimica et biophysica Sinica Vol. 44; no. 2; pp. 136 - 146 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
China
Oxford University Press
01.02.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | CS-1, a new alkaloid with a molecular formula of C21H2oOsN2S, is extracted from traditional Chinese medi- cine. Previous studies have shown that CS-1 can inhibit the proliferation of several human carcinoma cells in vivo and in vitro. The aims of this study are to investigate the anti-tumor effect and mechanism of CS-1 in epidermal growth factor receptor (EGFR) signaling pathway in human A431 cell line. Through the sulforhodamine B assay, we found that CS-1 inhibited A431 cell prolifer- ation in the concentration- and time-dependent manners. The inhibitory rate ranged from 14.5% to 87.8% after 24 h of incubation. High content screening (HCS) multi- parameters cytotoxicity analysis showed that CS-1 at high concentration had slight cytotoxicity that resulted from the cell permeabilization and slight reduction in total mitochondrial mass, whereas no change in nucleus size/ morphology and lysosomal mass-pH was found. The cyto- toxicity of CS-1 was not a major reason for its anti- proliferative effect. Cell cycle analysis indicated that CS-1 induced Gl-phase arrest in A431 cells in a time- dependent manner at high concentration (2.5 ttM), and S-phase arrest at low concentration (0.625 ttM). The HCS assay also showed that CS-1 could inhibit the EGFR in- ternalization, extracellular-signal-regulated kinase (Erk)/ mitogen-activated protein kinase translocation to nucleus, the accumulation of phosphorylated protein kinase B (Akt), signal transducer and activator of transcription 3 (STAT3), and cyclin D1 in the nucleus. These results were confirmed by the western blot analysis. CS-I might inhibit the epidermal growth factor binding to its recep- tor, resulting in the inhibition of the accumulation of phosphorylated Erk and Akt, and STAT3 in the nucleus, and affecting the transcription of cyclin D1 and cell cycle arrest in G1/S phase. |
---|---|
Bibliography: | 31-1940/Q CS-1, a new alkaloid with a molecular formula of C21H2oOsN2S, is extracted from traditional Chinese medi- cine. Previous studies have shown that CS-1 can inhibit the proliferation of several human carcinoma cells in vivo and in vitro. The aims of this study are to investigate the anti-tumor effect and mechanism of CS-1 in epidermal growth factor receptor (EGFR) signaling pathway in human A431 cell line. Through the sulforhodamine B assay, we found that CS-1 inhibited A431 cell prolifer- ation in the concentration- and time-dependent manners. The inhibitory rate ranged from 14.5% to 87.8% after 24 h of incubation. High content screening (HCS) multi- parameters cytotoxicity analysis showed that CS-1 at high concentration had slight cytotoxicity that resulted from the cell permeabilization and slight reduction in total mitochondrial mass, whereas no change in nucleus size/ morphology and lysosomal mass-pH was found. The cyto- toxicity of CS-1 was not a major reason for its anti- proliferative effect. Cell cycle analysis indicated that CS-1 induced Gl-phase arrest in A431 cells in a time- dependent manner at high concentration (2.5 ttM), and S-phase arrest at low concentration (0.625 ttM). The HCS assay also showed that CS-1 could inhibit the EGFR in- ternalization, extracellular-signal-regulated kinase (Erk)/ mitogen-activated protein kinase translocation to nucleus, the accumulation of phosphorylated protein kinase B (Akt), signal transducer and activator of transcription 3 (STAT3), and cyclin D1 in the nucleus. These results were confirmed by the western blot analysis. CS-I might inhibit the epidermal growth factor binding to its recep- tor, resulting in the inhibition of the accumulation of phosphorylated Erk and Akt, and STAT3 in the nucleus, and affecting the transcription of cyclin D1 and cell cycle arrest in G1/S phase. CS-1; cell cycle; EGFR signaling pathway;high content screening ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1672-9145 1745-7270 |
DOI: | 10.1093/abbs/gmr111 |